Urogen Pharma's total assets for Q1 2025 were $247.62M, a decrease of -13.33% from the previous quarter. GB:0XOD total liabilities were $294.08M for the fiscal quarter, a -0.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.